Number of the records: 1
amifampridín
SYS d000077770 LBL 00000cz--a2200181n--4500 005 20250606222655.9 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D02.092.080.060.500 065 $a D03.383.725.050.060.500 066 $a 01 $c 03 150 $a amifampridín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Ruzurgi $2 eng 450 $w v $a 3,4-diaminopyridín $2 slo 450 $w v $a amifampridín fosfát $2 slo 450 $w v $a Firdapse $2 slo 550 $7 sllk_us_auth*d009465 $Y Neuromuscular Agents $w P $a látky neuromuskulárne 550 $7 sllk_us_auth*d026902 $Y Potassium Channel Blockers $w P $a blokátory draslíkových kanálov 665 $a 2019 (1978) $2 eng 680 9-
$i 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES. $2 eng 750 -2
$a Amifampridine $2 eng 980 $x M
Number of the records: 1